The Eighth Circuit has drawn sharp criticism after judges were accused of distorting federal procedure to deliver a ruling favourable to the Trump administration. Legal commentators have labelled the judges involved as
The FTSE 250 index has climbed to record highs, marking a significant milestone for mid-cap UK stocks and signalling renewed investor confidence in British equities. The index, which tracks the 250 largest
More
Emergent BioSolutions has undergone a series of sweeping restructuring efforts, eliminating senior roles and consolidating operations as part of a broad turnaround strategy. Joseph Papa, just two months into his role as
More
Employers across the United States are sitting on vast stores of workforce data that could help them avoid costly wage-and-hour disputes before they escalate. Most businesses already hold the relevant information inside
More
The conflict between Russia and Ukraine remains the largest and most destructive European war since the Second World War ended in 1945. Observers across the political spectrum have described it as one
More
4Imprint Group (FOUR) saw its shares climb sharply after the promotional products company published results that impressed investors across the market. The FTSE 250-listed business, which specialises in branded merchandise and direct
More
Eli Lilly’s second-quarter revenues surged to $23 billion, a 48% year-over-year increase that comfortably beat analyst consensus estimates of $20.6 billion. The result also represented a 16% sequential increase, a sharp acceleration
More
A federal district court has delivered a significant ruling that limits the government’s ability to claw back awarded grant funding based on shifting agency priorities. The U.S. District Court for the District
More
Brown Rudnick has completed the largest group lateral hire in its history, bringing aboard a 34-lawyer intellectual property litigation team from HSF Kramer. The move signals that large-scale group lateral hires remain
More
Private companies added only 44,000 jobs in July, falling well short of market expectations and marking a sharp slowdown from the previous month. The figure represents a significant drop from the downwardly
More
Johnson & Johnson has announced the retirement of Jennifer Taubert, 62, worldwide chair of J&J Innovative Medicine, after more than 21 years with the company. Taubert joined J&J’s executive committee in 2018
More